Clinical Study of QSOX1 as a Biomarker for Colon Cancer
NCT05827471 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2023-04-25
Summary
The goal of this observational study is to determine whether the secreted protein QSOX1 can be used as a molecular marker for early rapid diagnosis and accurate treatment of colon cancer.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Diagnosis of colon cancer
Clinical diagnosis results
Sponsors & Collaborators
-
Qianfoshan Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-07-01
- Primary Completion
- 2026-06-30
- Completion
- 2026-12-31
More Related Trials
-
S9304A Study of Protein Expression in Tumor Tissue Samples From Patients With Stage II or Stage III Rectal Cancer Enrolled in Clinical Trial SWOG-9304
NCT00972751 ·Status: COMPLETED
-
Next-generation Sequencing in Gastrointestinal Cancer
NCT03476057 ·Status: UNKNOWN
-
Prognostic Biomarker for CRC
NCT03928652 ·Status: UNKNOWN
-
The Efficacy of JS001 Combined With Chemotherapy in Patients With Locally Advanced Colon Cancer
NCT03985891 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Comparison of Expression of Carcinogenesis-related Molecular Markers in the Patients With Colon Cancer and Polyp
NCT05638542 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer
NCT01012804 ·Status: WITHDRAWN
-
mFOLFOX6+Bevacizumab+PD-1 Monoclonal Antibody in Local Advanced MSS CRC
NCT04895137 ·Status: COMPLETED ·Phase: PHASE2
-
FOS Immunohistochemical Staining of Colorectal Cancer and Its Adjacent Tissues
NCT05698082 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer
NCT03038217 ·Status: UNKNOWN ·Phase: PHASE3
-
Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer
NCT07154173 ·Status: RECRUITING
-
Significance of Cortactin Expression in Colorectal Adenocarcinomas
NCT05225870 ·Status: COMPLETED ·Phase: NA
-
An Exosomal microRNA Signature for Preoperative Staging in Colon Cancer
NCT07255729 ·Status: RECRUITING
-
The Culture of Advanced/Recurrent/Metastatic Colorectal Cancer Organoids and Drug Screening
NCT05304741 ·Status: UNKNOWN
-
Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer
NCT06904677 ·Status: RECRUITING
-
Neoadjuvant Immunotherapy in Locally Advanced Colon Cancers
NCT05833672 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)
NCT07283575 ·Status: RECRUITING
-
Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC
NCT06002789 ·Status: RECRUITING ·Phase: PHASE2
-
Fecal and Oral Microbiota Between Pancreatic Cancer and Benign/Low-grade Malignant Tumor Patients
NCT06659237 ·Status: COMPLETED
-
Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
NCT06751914 ·Status: RECRUITING ·Phase: NA
-
Identification the Expression of Sox2 in Colorectal Cancer Tissues
NCT01589900 ·Status: COMPLETED
-
An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)
NCT05340231 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Clinical Study on the Efficacy of Autologous Cell Factor Induced Killer Cells in the Treatment of Colorectal Cancer
NCT05676190 ·Status: RECRUITING ·Phase: NA
-
Detect Microsatellite Instability Status in Blood Sample of Advanced Colorectal Cancer Patients by Next-Generation Sequencing
NCT03561350 ·Status: UNKNOWN
-
Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients
NCT02022995 ·Status: COMPLETED
-
The Effect of Unfavorable Histological Features on the Oncological Outcomes of Colon Cancer
NCT03794193 ·Status: UNKNOWN